SLDB | Solid BiosciencesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history

$6.28
+$0.28 (+4.67%)

Solid Biosciences (SLDB) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2018.

Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Jul 2025, but the two have been closing on each other and a death cross is projected within 10 bars. On both the daily and the 4-hour, price sits below the 50 and the 200; on the weekly it is between the two.

Timeframe summary

Daily as of 3 Nov 16:00 ET

Price
below both $6.28 vs 50 $7.69 / 200 $7.67
Projection
Death cross projected in 1 bar
Test
No active test
Last cross
Golden cross 25 Jul 2025 ยท projected 25 bars out

Weekly as of 30 Oct 16:00 ET

Price
between the two $6.20 vs 50 $7.27 / 200 $6.19
Projection
No cross projected
Test
No active test
Last cross
Golden cross week of 1 Jun 2026 ยท projected 14 bars out ยท tested 1 bar

4-hour as of 3 Nov 13:30 ET

Price
below both $6.18 vs 50 $6.38 / 200 $8.32
Projection
No cross projected
Test
No active test
Last cross
Death cross 7 Oct 2026 ยท projected 29 bars out

Cross history

25
crosses on record since 2018
13 golden12 death
Full cross history โ†’
CrossedDirectionTimeframeProjectedCross test
7 Oct 2026Death4-hour29 bars outNot tested
24 Jun 2026Golden4-hour10 bars outNot tested
9 Jun 2026Death4-hour8 bars out2 bar cross test
week of 1 Jun 2026Golden moderateweekly14 bars out1 bar cross test
30 Dec 2025Golden4-hour12 bars out6 bar cross test

About SLDB

ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$8.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2018
SectorHealthcare
Cap bandsmall

Cruxta · 50/200 moving-average crosses on US equities. Recorded crosses are observations. Projected crosses are projections, not advice.